This site requires JavaScript to be enabled to work properly. Please modify your settings or use a different browser to continue

      

You are now leaving GSK’s website

You are now leaving a GSK Website. By clicking this link, you will be taken to a website that is not owned or controlled by GSK, and GSK is not responsible for the content provided on that site

Continue

Go back

Apr 2023

Do patients and physicians have differing knowledge of and attitudes towards AR and its treatment? To answer this question, the KAPPA study surveyed 1,436 patients and 1,637 physicians from eight countries.1 Results from KAPPA suggest that although patients and doctors agree that AR symptoms can be controlled with treatment, their views about the severity of the symptoms and the optimal choice of treatments differ.1 KAPPA uncovered a need for improved education and communication within and between these groups.1

 

Read more

References:

  1. Bhargave C et al. J Asthma Allergy 2022;15:1645–64.

To report an Adverse Event, please contact the toll free line 0800 CALL GSK (0800 2255 475) or send an email